The effect of a single treatment with 30 mg dimethylnitrosamine (DMN) and 6 ,ug actinomycin D (ACT), given at different time intervals (ACT application to DMN, 2 h before, simultaneously, 5, 9 or 48 h later), was tested in female Sprague-Dawley rats in relation to renal carcinogenesis; additionally, the animals were fed either a normal or a protein deficient diet.
Summary.-The effect of a single treatment with 30 mg dimethylnitrosamine (DMN) and 6 ,ug actinomycin D (ACT), given at different time intervals (ACT application to DMN, 2 h before, simultaneously, 5, 9 or 48 h later), was tested in female Sprague-Dawley rats in relation to renal carcinogenesis; additionally, the animals were fed either a normal or a protein deficient diet.
The ACT treatment did not significantly modify either the kidney tumour incidence or the survival time in the different groups fed a normal diet. Nevertheless, there are indications that additional ACT application may shorten the latency period for DMN induced renal neoplasms or, when administered 5 h later than DMN, a slightly decreased and delayed tumour induction can be assumed. In groups fed a protein deficient diet, a significantly higher percentage of kidney tumour bearing animals as well as a shortened latency period were found when compared with the DMN group on normal diet, but these differences were independent of the additional ACT treatment 9 h later than DMN and were due to the protein deprivation. Morphologically, the tumours were of epithelial and mesenchymal type with a clear preponderance of the former type. Biochemical and morphological aspects are discussed.
THE DEVELOPMENT of tumours in mary neoplasms in rats induced by the some animal species exposed to carcinosame compound (Anderson and Kellen, genic substances may be modified by 1971; Gardner, Kellen and Anderson, secondary treatments. The antibiotic 1973; Tominaga, Taguchi and Shiba, actinomycin D (ACT), which can bind to 1973). Stewart and Magee (1973) , how-DNA and inhibit the DNA dependent ever, have shown that in protein depleted RNA synthesis (Kirk, 1960;  Kersten, rats ACT did not modify the incidence of Kersten and Rauen, 1960; Reich et al., dimethylnitrosamine (DMN) induced renal 1961; Flamm, Banerjee and Counts, 1966 ; tumours but did affect the survival time of Stewart and Farber, 1968; Bates et al., rats bearing the tumours. 1968; Hennings et al., 1968; Threlfall and As a continuation of this experiment, Taylor, 1969; Krugh, 1972) , inhibits the the effect of a single treatment with DMN induction of skin tumours in mice by and ACT in different combinations was 7,1 2-dimethylbenz(a)anthracene (DMBA) studied in rats with regard to renal (Gelboin, Klein and Bates, 1965; Hennings carcinogenesis. Additionally, either a and Boutwell, 1967; Bates et al., 1968 ) normal or a protein deficient diet was fed and also reduces the incidence of mam-since protein depletion is known to in-* Presente(d in part at the Xlth International Cancer Congress, Florence, Italy, October, 1974. fluence the toxicity and the carcinogenic chi-square test, and for the incidence of effect of DMN by inhibition of the drug kidney tumours per animal as well as the metabolizing enzymes in the liver average survival times in the various groups, (McLean and Verschuuren, 1969;  McLean the U-test after Mann and Whitney (1947) and .
were performed.
MATERIALS AND METHODS

RESULTS
Three hundred and thirty female Sprague- given 2 h before DMN, in Groups 5, 6 and 7, a few carcinosarcomata), the lymphatic ACT was injected simultaneously 5 h or 48 h system (malignant lymphomata, reticuafter DMN. In Groups 8-11 the treatment losarcomata and thymomata), the nasal with saline, DMN and ACT alone or DMN and paranasal cavities (papillomata, and ACT 9 h later were combined with a squamous and adenocarcinomata, estheprotein deficient diet (Hope Farms RMH-sioneuroepitheliomata), the heart (neu-TMB/ McLean and McLean, 1966) . The diet rofibromata and one neurofibrosarcoma), was given 1 week before and 1 week after the adrenal gland (cortical adenomata) as treatment.
well as other various organs (Table I) . All animals died spontaneously or were A s killed when moribund. Except for a few Averae survval t mes and tumour dcianimals lost through cannibalism, all were dence in Group 3 (ACT, normal diet), completely autopsied, the organs fixed in 4% Group 8 (NaCl, protein deficient diet) and buffered formalin and processed for routine Group 10 (ACT, protein deficient diet) are histological examination. Eight graded his-comparable with the control Group 1 tological sections were made from each (NaCl, normal diet), except for the kidney. The effective number of animals occurrence of one kidney (tubular carci- (Table I) is based on the number of rats noma) and one coronary (neurofibrosurviving after the first tumour of any site sarcoma) tumour in Group 10, usually (28 weeks) had been observed. For statis-seen only in the DMN treated groups. tical evaluation according to the method of Cutler and Ederer (1958) , the percentage of e doe oACT used ln the present kidney tumour bearing animals was calcu-experiment was much less than that lated in 4-week intervals and cumulated required to produce acute toxic symptoms (cumulative per cent, Fig. 1, 2) . For statis-or to induce tumours (Svoboda, Reddy tical comparison of the kidney tumour and Harris, 1970).
bearing animals in the different groups, the In Table II the kidney tumour incidence in the different 44th or 52nd week after beginning treatgroups are listed. The renal neoplasms, ment. For the period from the 64th until which occurred bilaterally in a certain the 72nd week, these 3 groups demonnumber of animals, showed a clear strated a significantly higher cumulative preponderance of epithelial over mesen-percentage of rats with renal neoplasms chymal tumours in all groups. compared with Group 2. An exception to Comparing the percentage of kidney the 3 aforementioned combination groups tumour bearing animals of Group 2 was made by Group 6 (DAIN, ACT 5 h (DMN, normal diet) with those in each later). In this group, the first tumour was other group treated with DMN, ACT and seen at the same time as in Group 2 but normal diet (Groups 4-7), no significant subsequently the cumulative percentages difference (P > 0.05) was found. Howare remarkably lower than in the DMN ever, in Groups 9 and 11 (DMN or DMN Group 2. This difference was statistically and ACT with protein deficient diet), the significant only for the period from 112 incidence of 100% and 9288%, respecto 116th weeks of the survival time;
tively, of kidney tumour bearing animals however, for the periods from 92nd to was significantly increased (P < 0.01) 96th and 104th to 112th weeks borderline compared with Group 2. values (0G1 > P > 0.05) were found.
Since comparison of the number or
The shortened latency period for percentage of tumour bearing animals induction of kidney tumours in Groups 4, based on the initial number of rats can be 5 and 7 was not statistically significant misleading if deaths due to causes other (P > 0 1) in comparison with Group 2. than the observed tumours occurred at In Fig. 2 Groups 9 and 11 (which different rates in the various experimental received protein deficient diet and DMN groups, the cumulative percentage for rats or DMN and ACT 9 h later) are plotted in with renal neoplasms has been calculated relation to Group 2. For the period from in 4-week intervals (Cutler and Ederer, the 52nd (Group 9) or 44th week (Group 1958). In Fig. 1 the results for Group 2 11) until the 104th (Group 9) and 100th (DMN, normal diet) and Groups 4-7 (Group 11) of the survival time, significant (combined treatment of DMN and ACT, differences between the cumulative pernormal diet) are plotted. While in Group centages were found. Here, the shortened 2 the first renal neoplasm was seen in the latency period for renal tumour induction 76th week, in Groups 4, 5 and 7 the first was highly significant (0 001 < P < renal tumours appeared as early as in the 0 002). Differences in kidney tumour inci-chymal tumours could be diagnosed (Fig. dences per animal in Groups 4-7 as well as 5). The morphological patterns of the 9 and 11 failed to be statistically signifirenal neoplasms were similar for all groups. cant when compared with the incidence Among the other types of tumours, per animal in the DMN Group 2. Only for marked differences were observed only for Group 6 (DMN, ACT 5 h later; normal nasal cavity and heart tumours, which diet) was a borderline value (0.1 > P > occurred mainly in those groups receiving 0.05) obtained.
DMN and ACT in different combinations
Macroscopically, the induced kidney (Groups 4, 5, 6, 9 and 11). Since a single tumours showed mostly grey-white dosage of 30 mg DMN can induce also nodules (Fig. 3) , increasing in size with a nasal cavity (Montesano et al., 1974) and tendency to necroses and haemorrhages. neurogenic coronary tumours (Haas, Hil- In one kidney up to 5 tumours were found. frich and , it seems that in Pulmonary metastases were observed only relation to the average survival time, only rarely. Histologically, the renal neo-the induction of nasal cavity neoplasms plasms were predominantly tubular adeno-in Group 11 (DMN, ACT and protein mata and carcinomata with expansive deficient diet) was slightly increased growth ( Fig. 4) ; in a few cases, mesen- (Table I) 
DISCUSSION
latency period in protein deprived rats. The present studies only partially
The most obvious exception in the confirm the findings of Stewart and results is made by Group 6, which Magee (1973) , who claimed that ACT did received DMN and ACT 5 h later together not modify the incidence of DMN induced with a normal diet. Though, in comrenal tumours but did significantly shorten parison with Group 2, no clearly significant the survival time of tumour bearing rats differences could be demonstrated, a fed a protein deficient diet. In those rats possible effect upon the time of appearfed a normal diet and treated with ACT ance as well as the total incidence of renal 2 h before or 48 h after DMN as well as neoplasms in this group cannot be ex-ACT simultaneously with DMN (Groups 4, cluded. The time of ACT injection 5 h 5 and 7), a remarkably shortened latency later than DMN is possibly the causal period for the induction of kidney tumours factor for the "delayed" and " dewas observed; but comparing the average creased " kidney tumour development. survival times of animals with renal Stewart and Magee (1973) could demonneoplasms in these 3 groups with Group 2 strate that a single dose of ACT adminis-(DMN alone, normal diet) no statistically tered 24 h after DMN can inhibit the significant difference was found, even stimulated renal DNA synthesis following though the cumulative percentage around the application of DMN; however, this the 70th week was statistically higher in inhibition was dose-dependent and the these 3 groups. It was suggested that dosage of 12 ,ug/kg b.w. ACT (double our possibly the known inhibitory effect of dose) was insufficient to prevent DMN ACT on the immune response (Wust, Gall stimulated DNA synthesis. Similarly, and Novelli, 1964) may shorten the using a higher ACT dosage (25 ,tg/kg latency period for the induction of kidney b.w.) than in this study, Threlfall and tumours (Stewart and Magee, 1973) . Taylor (1969) found a very marked The differences in absolute percentages of depression of DNA synthesis in the kidney tumour bearing animals in the 3 kidney when ACT was administered aforementioned combination groups were between 0 and 4 h after folate; with higher but not statistically significant to longer intervals, this depression became Group 2. less marked and after 20 h no effect was In rats deprived of protein (Groups 9 observed. Accordingly, the low ACT dose and 11) and treated with either DMN or used in the present study failed to have DMN and ACT, a significantly increased such an effect and the possibly reduced kidney tumour incidence and shortened and delayed tumour induction in this latency period were found compared with group might be related to other factors, Group 2. However, contrary to the e.g., perhaps discrete biochemical reactions findings of Stewart and Magee (1973) , in the kidney at this time of ACT applicahere the additional ACT treatment 9 h tion after DMN. after DMN neither remarkably modified
The morphological aspects of the renal the incidence of renal neoplasms, nor the neoplasms reported here were analogous latency period nor the survival time. to those previously described by various The deficiency of protein depresses the authors (Magee and Barnes, 1962 ; Riopelle activity of the enzyme system in the liver and Jasmin, 1969; Hard and Butler, that metabolizes DMN to a toxic and 1970; Stewart and Magee, 1973) . It is carcinogenic alkylating agent, whereas noteworthy that in this experiment nearly the metabolism in the kidney is not 100% epithelial neoplasms were found in considerably altered (McLean and Magee, the kidney while the above mentioned 1970; Stewart and Magee, 1971) . It is authors observed a very high percentage assumed that this fact explains the higher of mesenchymal renal tumours after kidney tumour incidence and shortened DMN treatment. As the route of DMN administration was the same as in the cited experiments, it can be suggested that, excluding rat strain differences, the age of the animals at treatment is probably decisive for the induction of either mesenchymal or epithelial kidney tumours. Using 5-and 5-7 week old rats Hard and Butler (1970) and Stewart and Magee (1973) , respectively, observed after single injections of between 30 and 60 mg/kg b.w. DMN that more than 50% of all renal tumours were of mesenchymal origin. In reference to our findings after DMN treatment in [12] [13] [14] week old rats, it seems that in younger rats the mesenchymal tissue is more sensitive to a carcinogenic effect of DMN while the tubular cells are more " responsive " in older animals. Moreover, in all of these experiments additional treatments of protein depletion and/or ACT application did not remarkably change the induction of either epithelial or mesenchymal kidney tumours.
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